Publicacións (99) Publicacións de ANTONIO JOSE MERA VARELA

2024

  1. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank

    Clinical and experimental rheumatology, Vol. 42, Núm. 2, pp. 277-287

  2. Quantification of temporomandibular joint space in patients with juvenile idiopathic arthritis assessed by cone beam computerized tomography

    Orthodontics and Craniofacial Research, Vol. 27, Núm. 2, pp. 203-210

2023

  1. Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression

    Arthritis Research and Therapy, Vol. 25, Núm. 1

2022

  1. Antibodies against 4 Atypical Post-Translational Protein Modifications in Patients with Rheumatoid Arthritis

    Diagnostics, Vol. 12, Núm. 2

  2. Leptin in Osteoarthritis and Rheumatoid Arthritis: Player or Bystander?

    International Journal of Molecular Sciences, Vol. 23, Núm. 5

  3. Progranulin in Musculoskeletal Inflammatory and Degenerative Disorders, Focus on Rheumatoid Arthritis, Lupus and Intervertebral Disc Disease: A Systematic Review

    Pharmaceuticals, Vol. 15, Núm. 12

  4. ROCK inhibition with Y-27632 reduces joint inflammation and damage in serum-induced arthritis model and decreases in vitro osteoclastogenesis in patients with early arthritis

    Frontiers in Immunology, Vol. 13

  5. TMJ contrast enhancement in CBCT images using a new algorithm

    Acta Radiologica Open, Vol. 11, Núm. 1, pp. 205846012210745

  6. WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes

    Laboratory Investigation, Vol. 102, Núm. 9, pp. 989-999

2021

  1. Monomeric C reactive protein (mCRP) regulates inflammatory responses in human and mouse chondrocytes

    Laboratory Investigation, Vol. 101, Núm. 12, pp. 1550-1560

  2. Pachydermodactyly: a systematic review

    Irish Journal of Medical Science, Vol. 190, Núm. 3, pp. 1005-1014

  3. Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome

    Scientific Reports, Vol. 11, Núm. 1

  4. Secukinumab in patients with psoriatic arthritis and axial manifestations: Results from the double-blind, randomised, phase 3 MAXIMISE trial

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 5, pp. 582-590

2020

  1. A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis

    Scientific Reports, Vol. 10, Núm. 1

  2. All-trans retinoic acid inhibits migration and invasiveness of rheumatoid fibroblast-like synoviocytes

    Journal of Pharmacology and Experimental Therapeutics, Vol. 372, Núm. 2, pp. 185-192

  3. Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 5, pp. 1101-1108

  4. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: A multicentric matched cohort study

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 12, pp. 1544-1549

  5. Influence of MUC5B gene on antisynthetase syndrome

    Scientific Reports, Vol. 10, Núm. 1

  6. Levels of the novel endogenous antagonist of ghrelin receptor, liver-enriched antimicrobial peptide-2, in patients with rheumatoid arthritis

    Nutrients, Vol. 12, Núm. 4

  7. Non-Canonical WNT5A Signaling Through RYK Contributes to Aggressive Phenotype of the Rheumatoid Fibroblast-Like Synoviocytes

    Frontiers in Immunology, Vol. 11